Mantle Irradiation for Hodgkin's Disease

Completed · Phase 2

Conditions studied: Hodgkin's Disease

In brief

The purpose of this study it to evaluate the effectiveness of radiation therapy limited to above the diaphragm in patients with pathological stage IA-IIA Hodgkin's disease.

Key facts

Study ID

NCT00165269

Run by

Dana-Farber Cancer Institute

People needed

100

Starts

1992-05-01

Expected to finish

2008-02-01

Last updated by the study team

2009-11-02

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Pathologically Stage IA-IIA Hodgkin's disease
• A negative staging laparotomy including splenectomy, biopsies of liver, paraortic nodal biopsies and palpitation of upper pelvic nodes
• 18 years of age or older

You may not qualify if…

• Patients with large mediastinal adenopathy
• Patients with LD histology
• Patients with "B" symptoms
• Positive laparotomy
• Subcarinal, hilar, or cardiac lymph node involvement

Where it is running

• Dana-Farber Cancer Center — Boston, Massachusetts, United States
• Massachusetts General Hospital — Boston, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.